메뉴 건너뛰기




Volumn 305, Issue 17, 2011, Pages 1806-1807

What next for QALYs?

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; NOTE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; UNITED STATES;

EID: 79955569726     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.566     Document Type: Note
Times cited : (36)

References (10)
  • 1
    • 77957958434 scopus 로고    scopus 로고
    • Legislating against use of cost-effectiveness information
    • Neumann PJ, Weinstein MC. Legislating against use of cost-effectiveness information. N Engl J Med. 2010;363(16):1495-1497.
    • (2010) N Engl J Med , vol.363 , Issue.16 , pp. 1495-1497
    • Neumann, P.J.1    Weinstein, M.C.2
  • 2
    • 79951641074 scopus 로고    scopus 로고
    • UK Secretary of State for Health December 16, Accessed April 15, 2011
    • UK Secretary of State for Health Department of Health. A new value-based approach to the pricing of branded medicines - a consultation. http://www.dh.gov.uk/en/Consultations/Liveconsultations/DH-122760. December 16, 2010. Accessed April 15, 2011.
    • (2010) A New Value-based Approach to the Pricing of Branded Medicines - A Consultation
  • 4
    • 33749355349 scopus 로고    scopus 로고
    • QALYs: Are they helpful to decision makers?
    • DOI 10.2165/00019053-200624100-00002
    • McGregor M, Caro JJ. QALYs: are they helpful to decision makers? Pharmacoeconomics. 2006;24(10):947-952. (Pubitemid 44497466)
    • (2006) PharmacoEconomics , vol.24 , Issue.10 , pp. 947-952
    • McGregor, M.1    Caro, J.J.2
  • 5
    • 77953714262 scopus 로고    scopus 로고
    • What outcomes should US policy makers compare in comparative effectiveness research?
    • Bridges JF, Buttorff C. What outcomes should US policy makers compare in comparative effectiveness research? Expert Rev Pharmacoecon Outcomes Res. 2010; 10(3):217-220.
    • (2010) Expert Rev Pharmacoecon Outcomes Res , vol.10 , Issue.3 , pp. 217-220
    • Bridges, J.F.1    Buttorff, C.2
  • 6
    • 0022633115 scopus 로고
    • Measurement of health state utilities for economic appraisal: A review
    • DOI 10.1016/0167-6296(86)90020-2
    • Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5(1):1-30. (Pubitemid 16098443)
    • (1986) Journal of Health Economics , vol.5 , Issue.1 , pp. 1-30
    • Torrance, G.W.1
  • 8
    • 61349157877 scopus 로고    scopus 로고
    • QALYs: Some challenges
    • Nord E, Daniels N, Kamlet M. QALYs: some challenges. Value Health. 2009; 12(1)(suppl 1):S10-S15.
    • (2009) Value Health , vol.12 , Issue.1 SUPPL. 1
    • Nord, E.1    Daniels, N.2    Kamlet, M.3
  • 9
    • 21744452666 scopus 로고    scopus 로고
    • It's not NICE to discriminate
    • DOI 10.1136/jme.2005.012906
    • Harris J. It's not NICE to discriminate. J Med Ethics. 2005;31(7):373-375. (Pubitemid 40945961)
    • (2005) Journal of Medical Ethics , vol.31 , Issue.7 , pp. 373-375
    • Harris, J.1
  • 10
    • 39049091057 scopus 로고    scopus 로고
    • Does preventive care save money? Health economics and the presidential candidates
    • DOI 10.1056/NEJMp0708558
    • Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? health economics and the presidential candidates. N Engl J Med. 2008;358 (7):661-663. (Pubitemid 351240744)
    • (2008) New England Journal of Medicine , vol.358 , Issue.7 , pp. 661-663
    • Cohen, J.T.1    Neumann, P.J.2    Weinstein, M.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.